Ziwig Endotest (Non-Invasive Diagnostic Test For Endometriosis)
A saliva test for the early and reliable diagnosis of endometriosis:
The Ziwig Endotest® is indicated for the diagnosis of endometriosis based on a miRNA signature, for female patients between the age of 18 and 43 years clinically suspected of endometriosis. It is a prescriptive-use only device, and saliva collection must be done under the supervision of a healthcare professional.
What is Endometriosis?
Endometriosis affects about 10% of women in the UK. It potentially affects all women and can present from adolescence.
Endometriosis is characterised by the presence of endometrial-like epithelium and/or stroma outside the uterine cavity (womb). The growth of these tissue fragments is frequently associated with an inflammatory process7. During menstruation, endometriosis lesions can react to variations in hormonal levels, leading to acute inflammation, bleeding, severe pain and many other symptoms.
Endometriosis can also be completely asymptomatic and is sometimes diagnosed during a consultation prompted by difficulty with conceiving. The prevalence of endometriosis in women with infertility is 30–50%.
Main symptoms of endometriosis:
For more information about the Ziwig Endotest please follow the link below: https://www.tdlpathology.com/specialties/genetics/ziwig-endotest/